Strancar Katja, Boniface Audrey, Blanot Didier, Gobec Stanislav
Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Arch Pharm (Weinheim). 2007 Mar;340(3):127-34. doi: 10.1002/ardp.200600191.
The increasing emergence of pathogenic bacterial strains with high resistance to antibiotic therapy has created an urgent need for the development of new antibacterial agents that are directed towards novel targets. We have focused our attention on the Mur ligases (MurC-F), which catalyze the early steps of bacterial peptidoglycan biosynthesis, and which to date represent under-exploited targets for antibacterial drug design. We show that some of our phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl:D-glutamate ligase (MurD) also inhibits UDP-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase (MurE). To obtain new information on their structure-activity relationships, three new, structurally related phosphinates were synthesized and evaluated for inhibition of MurD and MurE.
对抗生素治疗具有高度抗性的致病细菌菌株不断出现,这迫切需要开发针对新靶点的新型抗菌剂。我们将注意力集中在Mur连接酶(MurC-F)上,它们催化细菌肽聚糖生物合成的早期步骤,并且迄今为止,它们是抗菌药物设计中尚未充分开发的靶点。我们发现,我们的一些UDP-N-乙酰胞壁酰-L-丙氨酰:D-谷氨酸连接酶(MurD)的次膦酸酯抑制剂也能抑制UDP-N-乙酰胞壁酰-L-丙氨酰-D-谷氨酸:L-赖氨酸连接酶(MurE)。为了获得有关它们构效关系的新信息,合成了三种新的、结构相关的次膦酸酯,并评估了它们对MurD和MurE的抑制作用。